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The paper is based on a large qualitative study of ethics, policy and regulation of human embryonic stem
cell (hESC) science in Iran. This case study in ﬁve academic research centres used semi-structured in-
terviews to examine in depth the views of stem cell scientists, embryologists and ethics committee
members on hESC research policy in this Shia Muslim country. Although Iran’s policy approach has been
considered ‘intermediate’, what is described here seems to be a ‘more ﬂexible’ policy on hESC science.
This article describes three arguments to explain why Iran has shaped such a policy. These are: (1) a
ﬂexibility of the Shia tradition has allowed for hESC science; (2) permissive policy related to other ﬁelds
of biomedicine, such as new assisted reproductive technologies, facilitated approval of hESC research;
and (3) a lack of public debate of bioscience in Iran inﬂuences how its hESC research policy is perceived.
Based on the empirical data, this paper then expands and reﬁnes the conceptual bioethical basis for the
co-production of science, policy, and society in Iran. The notion of co-production implies that scientists,
policy-makers, and sometimes other societal actors cooperate in the exchange, production, and appli-
cation of knowledge to make science policy.
 2014 Elsevier Ltd. Open access under CC BY license.Introduction
The increasing use of human embryonic stem cell (hESC) lines for
research and therapy, as an innovation pathway, has stimulated
controversy internationally about the procurement, use and
disposal of the embryos. The debate over hESC research is mainly
caused by the diversity of ethical and policy issues. Social science,
the ethics literature and analysis of policy documents shape dis-
courses, debates, and shifts in this area of bioscience (see, e.g.,
Franklin, 2005; Isasi & Knoppers, 2006; Parry, 2003; Wainwright,
Williams, Michael, Farsides, & Cribb, 2006). Nations across the
globe have demonstrated widely divergent levels of tolerance for
allowing, funding and regulating hESC science. Taking a ‘conserva-
tive’ approach, some countries allow moral concerns to drive their
policy. Other countries take a more ‘progressive’ approach with
centralised regulated systems for hESC science (see Walters, 2004).
While several developed countries like the UK, have taken the
‘permissive’ approach based on long-standing regulation (Isasi &
Knoppers, 2006) or speciﬁc governance frameworks (Parry, 2006).ondon, First Floor, 22 Kings-
dom.
BY license.In developing countries, regulation of this ﬁeld is a new challenge;
responses range from severe restriction to nonspeciﬁc or even
nonexistent frameworks (Harmon, 2008; Isasi & Knoppers, 2006).
In the Muslim Middle East, only Iran, Turkey and Tunisia have
adopted a national policy on hESC science. According to the policy
literature, Iran (Walters, 2004) and Turkey (Ozturk Turkmen &
Arda, 2008) adopted an ‘intermediate’ policy that allow re-
searchers to utilise existing hESC lines and use embryos created but
not used for in vitro fertilisation (IVF). In contrast, Tunisia has
banned acquisition of embryos for experimental purposes and al-
lows them to be preserved only for therapeutic purposes, to help
infertile couples (Tebourski & Ammar-Elgaaied, 2004).
In 2002 Iran’s Supreme Leader, Ayatollah Khamenei, issued a
‘stem cell fatwa’ that declared that experimentation with human
embryos was consistent with Shia tradition and congratulated the
scientists who had produced hESC lines. (A fatwa is a religious
opinion about whether or not an action is permissible.) Iran’s
clerics and political leaders have also actively promoted science and
technology, in an attempt to enhance the country’s international
status. With the positive fatwa on the use of human embryos for
stem cell (SC) research and therapeutic goals, Iran became the ﬁrst
Muslim country to produce, culture and freeze hESCs (see
Baharvand et al., 2004). Rapid progress in SC science then led the
Iranian government to put in place ethical and scientiﬁc supervi-
sion of this ﬁeld of science. Compilation of the Speciﬁc National
Ethical Guidelines for Biomedical Research (for instance, guidelines
for genetic research and gamete and embryo research) has been a
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De Vries, 2008).
Thepurposeof this article is tobrieﬂypresent theviewsof Iranian
scientists, embryologists and ethics committee members about
Iran’s current hESC science policy and to examine some of the
reasoning behind their perception. It sheds light on the attitudes of
the participants noted above,who are relevant in understanding the
status of this ﬁeld and related policy, in Iran a ShiaMuslim country.
Method
Since little has been reported about the views of Iranian scien-
tists and other actors on hESC science, ethics and policy, a case
study design was chosen. The case study is an appropriate method
when a researcher wants to study a subject in its natural setting and
learn about the state of the art (Benbasat, Goldstein, & Mead, 1987).
The major research project chosen to be studied integrates data
from different sources using multiple methods, including ﬁeld-
work, internal archival research, and interviews with 30 senior and
junior scientists, embryologists and ethics committee members (15
females and 15 males) associated with hESC science, from ﬁve ac-
ademic SC research centres within Iran (The seniors interviewed
can be considered elites in that they all occupy positions in power
networks). To validate claims about the sites, an online search was
conducted for other sources to see if the ﬁndings from interview
data could be corroborated and to identify any contradictory evi-
dence (e.g., about the ethical guidelines on hESC research).
Following approvals by ethics committee at King’s College
London and the Royan Institute in Iran, ‘purposive’ and ‘snowball’
sampling (Silverman, 2010) was done for maximum variation of
ideas and perceptions, with the aim of recruiting enough numbers
to reach thematic saturation. Interviewees were recruited using
both formal and informal approaches and were given oral expla-
nations and information sheets describing the research. Between
March and May 2010 the interviews were conducted in Persian as
guided conversations (Loﬂand & Loﬂand, 1984) lasting 55e170 min
(average 95); an in-depth, semi-structured format allowed in-
terviewees to use their own words and shape the discussion in
ways related to their experience. None of the respondents objected
to their interviews being quoted anonymously. Broad sets of
questions covered interviewees’ understanding of hESC science and
policy and their general awareness of the contextual factors
shaping the ﬁeld.
All interviews were fully transcribed and then translated into
English by the author, who is ﬂuent in both languages, and a the-
matic approach was used to analyse the transcripts. The analysis
and the themes that emerged were discussed with the author’s
supervisors and colleagues. This paper quotes from interviewees
involved in science policy-making (12 interviews from 3 sites). It is
important to note that though the quotes are typical of those
interviewed for this study; they may not be generalisable to the
wider scientiﬁc and academic community in Iran. To preserve an-
onymity, study numbers were assigned and reference to occupa-
tions is in general terms rather than by speciﬁc job titles. For
instance, the category of ‘scientist’ could be used for those involved
in producing the lines and for those who differentiate them into
different kinds of cells.
Results
Themes
This analysis is organised into two major themes, each with
several subthemes to help explain the overall ﬁndings of Iran’s
current policy on hESC science. Each theme corresponds toembedded, inter-related ethical, social, legal and religious debates
over Iran’s hESC science policy.
(Un)certain hESC science policy
Several different perceptions of hESC policy emerged in the in-
terviews, in which some participants also expressed views that
spanned more than one subtheme. Their comments mainly refer to
Iran’s current policy for hESC research, such as encouraging, more
ﬂexible, liberal and/or open-minded.
Encouraging. The ﬁrst category is closely aligned with the ofﬁcial
fatwa from Iran’s Supreme Leader:
They [the Iranian government] somehow encourage [scientists] to
do this kind of [research]. This ﬁeld, it seems, can respond to many
human problems, related to [medical] disorders, war-damaged
people, and many scientiﬁc questions. (Scientist/7/Male)
Another interviewee added further details to this quote in
explaining that:
[Ethics policy] doesn’t restrict our research activity. Our country
fortunately emphasises the importance of improving research,
discovering human creation, and helping patients. (Scientist/1/
Male)
Several interviewees said that it had been encouraging when
Ayatollah Khamenei publicly supported the ﬁeld in 2002. For the
Supreme Leader, the main reason for doing hESC research was its
‘global beneﬁt’ for human beingsdhe encouraged scientists to
advance the technology to save lives, considering it a religious duty
to carry out research in order to develop new medicines and
technologies that can beneﬁt humanity. Iran’s goal should also be to
become the ‘leader of science’ in the Middle East in the next 20
years (Khamenei, 2007). The scientiﬁc progress of Iranian science
has been demonstrated by Rudolf Jaenisch’s paper published in
Nature (Jaenisch, 2007) as well as a stream of articles in Science and
Nature about Iran’s progress in science. Dr. Baharvand, the head of
the Department of Stem Cell Research at the Royan Institute, stated:
“[The] vision is to efﬁciently put stem cell research ﬁndings into
operation in disease treatment to increase the level of health.”
(Morrison & Khademhosseini, 2006: 8). The task of scientists, then,
is to promote scientiﬁc progress and keep Iran on the leading edge
of discovery.More ﬂexible. With its ‘permissive’, ‘ﬂexible’ and ‘restrictive’ pol-
icies on hESC research, Iran has adopted a ‘ﬂexible’ policy, among
the categories described by Hoffman (2008), though some other
references named it as an ‘intermediate’ approach (see Isasi &
Knoppers, 2006; Walters, 2004). Adhering to this policy, Iranian
scientists would work only on ‘spare’ IVF embryos and they were
not allowed to generate embryos for research purposes. However, a
few interviewees considered the policy to be ‘open-minded’. For
instance, one ethics committee member noted that:
We should go towards treating human by this method [hESC
research and therapy] but we have to consider the ethical debates.
This is our duty. There is no prohibition [on hESC research] in Iran
and our policy is open-minded. Our research institutes are very
active in hESC science to ﬁnd the cure for debilitating diseases.
(Theologian/Ethics Committee Member/30/Male)
Several interviewees also drew attention to the use of the
somatic cell nuclear transfer (SCNT) technique to provide SCs
M. Saniei / Social Science & Medicine 98 (2013) 345e350 347for therapeutic purposes. One of the embryologists argued
that:
We use SCNT in animal research and plan to carry out this tech-
nique for obtaining human stem cells which are genetically
matched to the donor organism. (Embryologists/Ethics Committee
Member/26/Male)
Another one noted:
I think that all kinds of stem cell research, including therapeutic
cloning, should be encouraged. In my view therapeutic cloning is a
different matter [from reproductive cloning]. [.] It would be
indefensible to stop this research and deny people [patients] the
chance of new treatments which could save their lives. (Physician/
Ethics Committee Member/2/Male)
These quotes reﬂect the idea that the total prohibition of human
cloning was unacceptable and would block valuable research and
medical advances in treating debilitating conditions, such as cancer,
Alzheimer’s and Parkinson’s diseases, spinal cord injuries and so on.
The Supreme Leader often cites the Qur’an’s emphasis on pre-
venting human illness and suffering as evidence that SC research
and Islam are compatible; the fatwas permitting biomedical
research in Iran are the product of such science-friendly in-
terpretations. Iran’s stem cell fatwa stresses the admissibility of
destroying spare IVF embryos in order to collect SCs for research.
However, there are limits: the Supreme Leader has warned Iranian
scientists “to be careful that producing identical parts of human be-
ings does not lead to producing a human being.” (Iran News, 2013)
Human reproductive cloning is not accepted by many Muslim
scholars mainly because it could be considered misuse of the
woman who supplied the eggs. There is also a special concern that
any human born from such an experiment would be more likely to
suffer from impaired health and development. Moreover, some
Muslim scholars hold that the loss of kinship and lineage as a result
of the unnaturalness of reproductive cloning, as well as potential
social harms (Larijani & Zahedi, 2004).
Authorities in Iran tend to accept therapeutic cloning to produce
SCs, according to Larijani and Zahedi (2008:631): “The Islamic view
about when life begins has been used by Iranian jurists for issuing
fatwas on allowing stem cell research and cloning for therapeutic
purposes.” This policy is in favour of the potential beneﬁts of hESC
and therapeutic/research (but not reproductive) cloning. Iran’s
Ethical Guidelines on Human Embryonic Stem Cell Research and
Therapy, drafted by Nejad-sarvari, Emami-razavi, Larijani, and
Zahedi (2011) implies this policy on therapeutic cloning. However,
it is not permissible to transfer human somatic cell nuclear into
animal eggs.
Although the policy is seen as ‘open-minded’, some in-
terviewees emphasised the limits to ﬂexibility. In this quote an
interviewees argued that:
It might seem that Iran is open-minded. We might not have so
much limitation [in working on human embryos], but we’re not
allowed to create embryos for research, or animal-human hybrid
for therapeutic purposes. (Embryologist/20/Female)
One scientist also added, “I don’t think that Iran is ﬂexible. I think,
they work on this ﬁeld of research, because they have a religious
justiﬁcation and perhaps scientiﬁc interest.” (Scientist/8/Female)
Another scientist agreed, saying, “The country considers [hESC
research] as opportunity. Sometimes, I don’t think that they’re too
permissive, but they’re doing this research because it’s religiouslyjustiﬁed.” (Scientist/7/Male) One interviewee who considered Iran’s
policy to be ‘restrictive’ explained, “Islam has a careful deﬁnition of
full human beings, and based on this deﬁnition, I can say that Iran is
very strict about the use of human embryos for research purposes.”
(Scientist/27/Male)
Perceptions of Iran’s hESC science policy
Shia tradition and bioscience. The ontological status of pre-
implantation embryos is the most sensitive point in the long-
running dispute over hESC research. One concrete illustration of
the inﬂuence of ideology on bioscience and policy-making is the
use of embryos for SC research. As many interviewees noted, one of
the main reasons for this progressive approach is the role of Shia
tradition in supporting hESC science. One scientist argued that
Iran’s open-minded policy comes out of the Shia tradition which is
compatible with the development of science and said:
It [open-minded policy] is related to our beliefs. Shia [tradition]
says, “No problem, you can work on a human embryo,” which is
before ensoulment [the creation of a soul within a human being].
The embryo has potential to become a human being but it’s not yet
[a human being], [it] doesn’t have soul yet, so it’s allowed [to be
used]. (Scientist/3/Male)
For interviewee 3, Iran’s policy emerged from its people’s reli-
gious beliefs, which are based on in-depth examination of what
constitutes the moral status of human embryos, and whether the
practice of hESC research with all its ramiﬁcations would violate
human dignity. However, many Muslim scholars, both Sunni and
Shia, have approved creation of hESC lines for research and thera-
peutic use, even if that requires destruction of surplus IVF embryos,
because very few of the embryos will have the chance to develop
into mature human beings (Sachedina, 2009). The more plausible
view, for Muslim jurists, is that because human entities at the
beginning of life do not have a moral status, they can be used for
research purposes.
Several interviewees emphasised the importance of this reli-
gious justiﬁcation and its role in hESC science and policy in Iran.
One embryologist 25, who was a member of an ethics committee
said, “In Islam and particularly [in the] Shia [tradition], we can see
this open-minded approach to many newmatters [e.g., therapeutic
abortion]. Shia doesn’t restrict us to the limited action.” Scientist 17
added, “Even, in religious debates, we are different from other
[Muslim] countries. We are the only country with the Shia system
[because of the large Shia community], and take everything easier
than Sunni.”
Despite its reputation in the West for intolerant Islamic funda-
mentalism, Iran has relatively permissive legislation in several
areas of biomedicine, such as abortion, assisted reproductive
technologies (ARTs) and hESC research. Larijani and Zahedi (2006)
said that Shia Islam teaches that ensoulment takes place at 120 days
after conception (see also Saniei, 2012a, for more information about
Islam and embryonic development). This makes it possible for
Iranian physicians to do therapeutic abortions and for scientists to
perform hESC research and therapeutic cloning.
In 2005, the Iranian parliament passed a ‘therapeutic abortion
act’, which allows abortion after a diagnosis by three experts and
conﬁrmation by the ‘legal medicine organisation’. Abortion is now
legal during the ﬁrst four months of pregnancy in case of mentally
and physically handicapped foetuses (Bazmi, Behnoush, Kiani, &
Bazmi, 2008). According to Larijani and Zahedi (2006) the inci-
dence of birth defects seems to be rising in Iran. There is a prefer-
ence for consanguineousmarriage, which results in a higher level of
defects and, as in the West, the age of marriage for educated
women is rising in the country.
1 Ulama (singular: Alim, ‘scholar’) or Maraji (singular: Marja) are the supreme
legal authorities and the source of emulation, for Twelver Shia Muslims (followers
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science policy has been remarkably progressive in most area, but
also controversial inmany.Why does Iran take an approach to these
issues that is different from approaches in other parts of theMuslim
world? One interviewee argued that the main reason can be Shia
jurisprudence, because it utilises ijtehad (in Islamic law, the inde-
pendent or original interpretation of problems not precisely
covered by the Qur’an and the Prophet’s sayings) by adopting
reasoned argumentation in ﬁnding the laws of Islam. He then
stated:
Shia ﬁqh (jurisprudence) is more dynamic than Sunni ﬁqh, as we
use aql (intellect or reason) and Sunni rely more on strict readings
of Islamic texts. It’s our duty to use aql and be ﬂexible. Islam always
emphasise science. It’s very important for Muslims. Since the time
of the Prophet, many things have been discovered, and we should
adapt to them. It’s our duty to advance knowledge. (Theologian/
Ethics Committee Member/30/Male)
As a Shia Islamic country, Iran is inﬂuenced by a culturally-based
religious faith. While scientiﬁc and technological advances
continue to provide new challenges, Shia jurists have used several
principles of Islamic jurisprudence to ﬁnd valid solutions without
breaking Islamic law (Saniei, 2012a). For instance, legal principles
such as maslahat (public good) and istihsan (to deem something
preferable) promote what is beneﬁcial; and zarurat (necessity),
which overrules prohibition, might provide religious-legal justiﬁ-
cation and legitimisation (Sachedina, 2009). Senior Shia scholars
applied the principles of ijtehad and ijma’ (scholarly consensus) and
concluded that hESC research is permitted in certain circum-
stances, e.g., the use of pre-implantation and pre-ensoulment
embryos (Saniei, 2012a).
Another participant added:
For us [as Shia], the difference is we can be more ﬂexible in using
new science, as we can adapt the religious texts to modern society
through our own interpretations and reason. Because Islam,
particularly Shia Islam, emphasises science and new thinking, there
is no challenge between religion and science. When new things
come, Islam is able to accommodate. (Embryologist/Ethics Com-
mittee Member/26/Male)
These two quotes resonatewith a viewwidely held in Iran about
the perceived ﬂexibility of Shia tradition compared to Sunni. That is
not to say that other Muslims do not also use various methods of
logic in Islamic ﬁqh, but Iranians deﬁnitely perceive their own
system as more ﬂexible and dynamic when it comes to incorpo-
rating scientiﬁc advances into daily life. This ﬂexibility of religious
institutions vis-a-vis hESC science thus originates from the
perception that Shia allows adjustments to accommodate changes
within Islamic beliefs, while the Sunni doctrine is more strict. This
automatically allows the Iranian scientiﬁc community, where Shia
prevails, to have a comparative advantage over those in neigh-
bouring countries because they are permitted to work with hESCs
(see Saniei, 2012b for comparative policies among selected Muslim
nations).of the twelve Imams, the Prophet’s offspring) around the world. The concept of
Marja-i Taqlid (lit. source of emulation) is central to Usuli (principles) Shia Islam (see
http://www.globalsecurity.org/military/intro/islam-ithna-ashari2.htm). The Marja-i
Taqlid provides religious interpretations of matters of law and rituals. Ideally, the
most just and knowledgeable specialist in the ﬁeld of the Islamic law should
become recognized throughout the Muslim world as the Marja-i Taqlid. In practice,
however, this rarely happens, so there are several Marja-i Taqlid’s which an indi-
vidual is free to choose and emulate. Those clerics who reach the apex in the
theological hierarchy in the centres of Shia learning become Ulama or Marja-i
Taqlids.Analogy to the new assisted reproductive technologies. The diversity of
opinions on hESC science policy sometimes connects to the complex
views about what Iran’s policy is in other ﬁelds of bioscience and
technology. Some interviewees commented about the goals and
practices of other areas of biomedicine, for instance, the new ARTs,
such as third-party gamete and embryo donation. One interviewee,
in discussing bioscience policy said that:Of 57 Muslim nations, Iran is the only country which has surrogacy
and third-party egg, sperm and embryo donation. Iran thinks about
sex selection. We also have stem cell [therapy], [animal] cloning,
and PGD [pre-implantation genetic diagnosis]. The reason behind
the ARTs policy is the knowledge of our Ulama [also called Maraji]1
about the Islamic debates. According to them, “Everything is
permitted, unless there is a reason against that.” (Physician/Ethics
Committee Member/2/Male)
Another interviewee also drew attention to this subject and
argued that:
Our Ulama carefully assess debates surrounding hESC research. If
you look at similar research, such as third-party embryo donation,
you can ﬁnd that Iran precisely works based on religious discourse
and deliberation about ethics and bioscience. (Scientist/1/Male)
The endorsement and support of the religious authorities has
thus made the use of ARTs possible among the Muslims in the
Middle East. Marcia Inhorn (2006a) notes that the global spread of
these technologies is nowhere more evident than in the 22 nations
of the Muslim Middle East. In most Muslim countries, however,
application of these technologies is limited to IVF treatment only
for married couples; and third-party donation is not permitted
(Inhorn, 2006a). Shia Iran, as a theocratic state, has adopted all
forms of the new ARTs and has legitimised them, including third-
party gamete and embryo donation, surrogacy and sex selection
(Tremayne, 2009). With regard to Iran’s policy on ARTs, Inhorn
(2006b) says, “Iran is deﬁnitely in the lead among Muslim countries
in the Middle East in the application of these technologies.” The rea-
sons for and the process of legitimising the new ARTs in theMuslim
Middle East have been documented extensively elsewhere (Inhorn,
2006a; Tremayne, 2009). However, there is no religious fatwa,
governmental act or clariﬁcation in Iran’s biomedical guidelines
about sex selection.
Interviewees brought up this example to draw attention to Iran’s
open-minded policy on other ﬁelds of medical technology, such as
embryo donation for infertility treatment. By making an analogy
between newARTs and hESC research, they attempt to demonstrate
how the state policy has been applied to a variety of subjects. In
doing so, in response to this progressive approach, the scientiﬁc
community has shifted the ethical, social and legal focus from hESC
research to ARTs. It seems that the similarity between hESC
research and other bioscience ﬁelds like third-party embryo
donation helps interviewees to see Iran’s policy as ‘more ﬂexible’
and ‘open-minded’ and unlike the policies of most other Muslim
countries.
Lack of public debate. In contrast to many countries, public opinion
in Islamic countries like Iran, does not much inﬂuence on these
types of issues. Aramesh and Dabbagh (2007) explain that the rules,
regulations and practice in Iran are mainly based on fatwas, which
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pointed out that the lack of public debate could be one reason why
Iran’s policy seems ‘open-minded’. For example, in the following
interview one embryologist explained that:
It seems that Iran is so liberal [in terms of science]. [.] The public
don’t criticise us, and this might be the reason why they [other
countries] think that we’re liberal. It means that we don’t have any
sociocultural barriers. If we don’t inform them [the public] [about
our scientiﬁc activities], no one [asks any question or] stops us.
Even journalists don’t criticise us. (Embryologist/20/Female)
Similarly to this view another embryologist presented the
following argument:
I don’t agree that [Iranian] scientists are free. In Iran, when sci-
entiﬁc work progresses a little bit, for instance, based on individual
interest, the public might criticise them; [.] then [regulators] look
for a ruling about that (Embryologist/29/Female).
Taken together, these quotes may reﬂect the opinion that the
absence of public debate leads scientists, policy-makers and advi-
sory bodies to make defensive assumptions about what the public
might ﬁnd acceptable.
Some Islamic states oversee all aspects of life and sometimes
prevent the public from expressing their opinions, so the general
public has little inﬂuence on decisions made by politicians. Iran has
a centralised Shia authority, represented by the Grand Ayatollah,
who has the most religious and legislative power in the country.
The importance of this fact is that assessment and practice of any
subject are based upon religion, which more readily provides clear
and direct information about the country’s approaches to embryo
research, at least from a Shia perspective. Accordingly, once a
procedure has been allowed, scientists sometimes operate with no
accountability. This religious constitution, however, facilitates and
speeds up the policy- and decision-making process. It can even
allow for research when there is no legal regulation on a certain
subject (Saniei, 2012a). It seems that hESC research has the possi-
bility of a promising national and internationally future for regen-
erative medicine in Iran (Khamenei, 2007). Moreover, in Iran the
trend seems to point to growing optimism among patients towards
SC research (see Javadi et al., 2005); and thus the laws are open to
research on cell lines developed from embryonic cells.Discussion and conclusion
The emergence of major advances in biomedical technologies,
such as gamete and embryo donation, genetic testing, and SC
research and therapy, have led to redeﬁnition of what constitutes
life. In the West, the emotional and ethical disputes surrounding
these technologies have been substantial. Throughout the
Muslim world, the response has been equally fraught with moral
and religious concerns, and with a similar lack of consensus.
Fatwas on these modern debates vary among the different Is-
lamic schools of thought; these Islamic rulings actually reﬂect
local customs, cultures and moral sentiments. Marcia Inhorn’s
(2010) study comparing the Sunni and Shia approaches to gamete
donation and infertility treatment in Egypt and Lebanon pointed
to how different Islamic interpretations of what is permitted
inﬂuence government reproductive policies and individual
practices.
Individual countries have adopted different policies on the use
of embryos for SC research based on their sociocultural, political,
and even economic backgrounds. Isasi and Knoppers (2006: 9)noted that “the historical, cultural and sociological context, the
institutional framework, and the mobilisation of stakeholders are
factors that help explain why countries that seemingly share
similar socio-religious beliefs [and perhaps scientiﬁc interests]
have adopted diametrically opposite public policies.” Countries
with similar religious backgrounds and, perhaps, scientiﬁc interests
may therefore approach new knowledge in different ways as a
result of the mutual inﬂuence of cultural factors and science.
This paper adopts an interpretive approach to the science, so-
ciety and policy, which are understood as historically and culturally
situated (Haraway, 1991) and co-produced (Jasanoff, 2004) along
with the social contexts involved in their making. For Iran, intro-
duction of an Islamic system seems to have forced religious scholars
into an unprecedented role of responsibility and involvement in
social planning and public health. Having been faced with health
crises on a large scale may partially explain why religious scholars
have invoked maslahat and istihsan in their rulings on medical and
health affairs rather than considering these questions in an isolated
or theoretical sense, as was done in the past. The ﬁnancial burden of
debilitating diseases is also central to decisions about hESC
research in Iran. This may have given Shia scholars impetus to
reconsider the public health ramiﬁcations of degenerative and
incurable disorders or the ﬁnancial hardships that serious, long-
term illnesses have on individuals, families and society. The
eight-year Iran-Iraq war left the country with a large community of
people disabled by spinal cord injuries, among others, a fact that
provided intensive motivation for Iran to start many cell-therapy
research projects (see e.g. Javadi et al., 2005). In developing coun-
tries (e.g. Iran), domestic cell therapy and regenerative medicine is
also a low-cost solution for the growing number of patients with
chronic diseases, including diabetes, heart diseases, hepatitis, and
such blood diseases as thalassaemia, which are relatively prevalent
(Greenwood et al., 2006).
Along with high demand, a combination of surging science,
encouraging policies, and favourable ethical norms that make spare
embryos accessible for scientiﬁc research (Inhorn & Birenbaum-
Carmeli, 2008) are all contributing to push innovation forward.
Surely, that move could not have been accomplished without
interaction between scientists and non-scientistsdpolicy-makers
and other actors who have an interest in hESC and the policies that
affect it. Furthermore, technological innovation and scientiﬁc
achievement holds hope of a ‘golden age’ of intellectual and ma-
terial beneﬁts for the people of Iran, as the Supreme Leader asserted
in justifying the position of the country in the Muslim world.
This paper uses the case of hESC science in Iran as a vehicle to
explore the politics of innovation that shaped the co-production of
science, policy and society. The use of human embryos in hESC
research has raised fundamental sociocultural, moral and religious
issues about the relationship between human life and scientiﬁc
progress: issues thatmay collidewith science policy and regulation.
It is important that this collision be resolved in terms of how sci-
ence policy is constructed and understood, the authorities on
which it draws for legitimacy in its consideration of possible
science-culture conﬂict, and the sustainability of the policy
outcome given the range of actors involved.
Different perceptions of hESC science policy are constructed in
different ways. Based on the dominant narratives, this paper argues
that Iran’s policy on hESC research is ‘more ﬂexible’, ‘open-minded’
and ‘encouraging’ rather than simply an ‘intermediate’ approach;
and the science is closely intertwined with ethical, social, religious
and legal considerations. It contributes to the development of a
more socially embedded account of ethical deliberation about hESC
science policies and their effects and also to the social and policy
contexts of hESC research ethics. As this study continues, to date, no
systematic variation has been found in interviewee opinions on
M. Saniei / Social Science & Medicine 98 (2013) 345e350350ethical, social and legal issues in relation to their main scientiﬁc
interests and religious convictions.
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